Jack Nathan Medical Corp. (JNH.V)
| Previous close | 0.0500 |
| Open | 0.0500 |
| Bid | 0.0450 x N/A |
| Ask | 0.0600 x N/A |
| Day's range | 0.0500 - 0.0500 |
| 52-week range | 0.0400 - 0.1450 |
| Volume | |
| Avg. volume | 26,525 |
| Market cap | 4.355M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.0800 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Simply Wall St.Jack Nathan Medical Full Year 2024 Earnings: CA$0.078 loss per share (vs CA$0.079 loss in FY 2023)
Jack Nathan Medical ( CVE:JNH ) Full Year 2024 Results Key Financial Results Revenue: CA$19.1m (up 24% from FY 2023...
Business WireJack Nathan Health Announces Its Q4 and Year End Fiscal 2024 Financial Results
TORONTO, April 29, 2024--Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) ("Jack Nathan Health", "JNH" or the "Company") announced today its audited consolidated annual financial results for the fourth quarter of fiscal 2024, and fiscal year ended January 31, 2024. Jack Nathan Health’s financial statements are prepared in accordance with International Financial Reporting Standards ("IFRS").
Business WireJack Nathan Health Announces Its Q3 Fiscal 2024 Financial Results
TORONTO, December 12, 2023--Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) ("Jack Nathan Health", "JNH" or the "Company") announced today its unaudited interim consolidated financial results for the third quarter of fiscal 2024, nine months ended October 31, 2023. Jack Nathan Health’s financial statements are prepared in accordance with International Financial Reporting Standards ("IFRS").
